Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial

BACKGROUND: A quadrivalent split influenza vaccine IIV4-W against both influenza A and B viruses is urgently needed. METHODS: To evaluate the safety and immunogenicity of IIV4-W in people aged 3–60 years, 2400 participants recruited in a double-blind phase III trial and were randomly assigned to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaoyuan, Fan, Ting, Li, Li, Nian, Xuanxuan, Zhang, Jiayou, Gao, Xuefen, Zhao, Wei, Chen, Wei, Zhang, Zhaoqing, Yao, Zhihao, Han, Xixin, Shi, Jinrong, Wang, Ying, Bian, Haihe, Shi, Nianmin, Li, Xinguo, Duan, Kai, Li, Guohua, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Influenza – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621009/
https://www.ncbi.nlm.nih.gov/pubmed/35714276
http://dx.doi.org/10.1080/21645515.2022.2079924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621009/
https://www.ncbi.nlm.nih.gov/pubmed/35714276
http://dx.doi.org/10.1080/21645515.2022.2079924

Ejemplares similares